DAL vs URGN · P/E 12, rev $35.61B vs rev $123.4M
Delta Air Lines Inc (DAL) versus UroGen Pharma Ltd (URGN) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
UroGen Pharma Ltd (URGN) is a biotechnology company listed on NASDAQ.
Latest reported DAL revenue for 2026-06-30 was $35.61B. Net income was $1.31B. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported URGN revenue for 2026-06-30 was $123.4M. Net income was -$37.9M. URGN currently screens at market cap $1.61B.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. URGN currently screens at market cap $1.61B.
Not investment advice. Open the DAL and URGN stock pages for the full models.
Not investment advice.